Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
Top Cited Papers
- 11 May 2007
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 212 (2) , 209-217
- https://doi.org/10.1002/path.2175
Abstract
KIM‐1, a transmembrane tubular protein with unknown function, is undetectable in normal kidneys, but is markedly induced in experimental renal injury. The KIM‐1 ectodomain is cleaved, detectable in urine, and reflects renal damage. KIM‐1 expression in human renal biopsies and its correlation with urinary KIM‐1 (uKIM‐1) is unknown. In biopsies from various renal diseases (n = 102) and controls (n = 7), the fraction of KIM‐1 positive tubules and different renal damage parameters were scored. Double labelling was performed for KIM‐1 with macrophages (MØ), α‐smooth muscle actin (α‐SMA), proximal (aquaporin‐1) and distal (E‐cadherin) tubular markers and a dedifferentiation marker (vimentin). uKIM‐1 at the time of biopsy (n = 53) was measured by ELISA. Renal KIM‐1 was significantly increased in all diseases versus controls (p < 0.05), except minimal change. KIM‐1 was primarily expressed at the luminal side of dedifferentiated proximal tubules, in areas with fibrosis (α‐SMA) and inflammation (MØ). Independent of the disease, renal KIM‐1 correlated positively with renal damage, negatively with renal function, but not with proteinuria. uKIM‐1 was increased in renal patients versus controls (p < 0.001), including minimal change, and correlated positively with tissue KIM‐1 and MØ, negatively with renal function, but not with proteinuria. In conclusion, KIM‐1 is upregulated in renal disease and is associated with renal fibrosis and inflammation. uKIM‐1 is also associated with inflammation and renal function, and reflects tissue KIM‐1, indicating that it can be used as a non‐invasive biomarker in renal disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 27 references indexed in Scilit:
- Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinaseAmerican Journal of Physiology-Renal Physiology, 2007
- ADAM19 expression in human nephrogenesis and renal disease: Associations with clinical and structural deteriorationKidney International, 2006
- Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetesJournal of Clinical Investigation, 2006
- Tubulointerstitial damage and progression of renal failureKidney International, 2005
- Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell CarcinomaJournal of the American Society of Nephrology, 2005
- TIM-4 is the ligand for TIM-1, and the TIM-1–TIM-4 interaction regulates T cell proliferationNature Immunology, 2005
- Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injuryAmerican Journal of Physiology-Renal Physiology, 2004
- Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesionClinical and Experimental Immunology, 2002
- A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndromeKidney International, 2000
- Stage- and segment-specific expression of cell-adhesion molecules N-CAM, A-CAM, and L-CAM in the kidneyKidney International, 1993